
MEDRAD is a worldwide market leading manufacturer and distributor of high tech medical devices that enable or enhance diagnostic and therapeutic medical procedures for computed tomography, magnetic resonance, and cardiovascular applications.
MEDRAD's E-Mail Education Bulletin will help you stay in touch with clinical and industry issues affecting medical imaging.
Subscribe today >>
MEDRAD has built a reputation for reliable products and customer support.
Read about MEDRAD's brand promise and view the Performance. For life. video >>
Three different centers show that advances in imaging using MEDRAD's 3.0T eCoil™ Endorectal Coil facilitate diagnosis, localization, staging, and treatment of prostate lesions. Read Multi-parametric 3.0T MRI provides excellent prostate imaging >> ![]()
The Association for Manufacturing Excellence (AME) presented the MEDRAD Heilman Center Electro-Mechanical Manufacturing Plant with the national Manufacturing Excellence Award. Find out more >>
MEDRAD Interventional/Possis, the new endovascular-focused division of MEDRAD, announced that it is a sponsor of the ATTRACT trial which will evaluate the long-term benefits of using the company’s AngioJet® Rheolytic™ Thrombectomy System in combination with clot-softening drugs to provide more rapid endovascular treatment of Deep Vein Thrombosis (DVT).

MEDRAD announced that the Continuum Wireless version of its Continuum MR Infusion System has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The new wireless option for control of medication infusion inside or outside the MR scan room will increase workflow efficiencies and throughput while enhancing clinician confidence.
Read >>
November 24, 2008
MEDRAD Builds on Success of P3T™ Cardiac CT Injection Software
November 13, 2008
MEDRAD Multi Vendor Service Forms Alliance with Wetsco
October 14, 2008
New Cardiovascular Products Division Launches at TCT2008
September 22, 2008
MEDRAD Interventional™/Possis® to Co-Sponsor ATTRACT Trial, Evaluating Long-Term Benefits of New Treatments for Deep Vein Thrombosis
September 12, 2008
Over 900 MEDRAD® Employees Volunteer Time, Resources Today